Ƶ

Drug Shortages Hit Oncology; Telemedicine Tops In-Person; Sniffing Out Lung Cancer

— News, features, and commentary about cancer-related issues

Ƶ MedicalToday

With about , oncology ranks in the top five clinical areas most affected by shortages. (CNN)

Telemedicine in-person visits for cancer patients at one center with respect to access to care and provider response. (Journal of the National Comprehensive Cancer Network)

Citing deficiencies at a third-party manufacturing plan, the FDA ImmunityBio's application for the IL-15 superagonist N-803 for bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer. (Endpoints News)

Innovent announced confirming the superiority of adding sintilimab to chemotherapy with or without bevacizumab (Avastin) for longer progression-free survival in non-small cell lung cancer, and noted that the three-drug combination demonstrated a trend toward improved survival.

Too many older men continue to be . (New York Times)

More evidence that can help improve survival in lung cancer. (JAMA Network Open)

A federal district court in a lawsuit filed by Ipsen, maintaining that the agency erred in classifying the somatostatin agonist lanreotide (Somatuline Depot) as a drug rather than a biologic agent, a decision that has implications for development of generics. (Endpoints News)

A laser-based "digital nose" developed for COVID diagnosis may also . (University of Colorado Boulder, Journal of Breath Research)

Elevated levels of may identify patients with hormone-sensitive prostate cancer on androgen deprivation therapy who have poor odds of survival. (University of California Davis, European Urology)

A review of 14 studies involving a total of 105,000 patients showed that may help reduce the risk of cancer death. (Ageing Research Reviews)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined Ƶ in 2007.